HomeInsightsStock Comparison

Biocon Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Biocon Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Last Updated on: May 20, 2025

Key Highlights

  • The Latest Trading Price of Biocon Ltd is ₹ 342.95 as of 20 May 09:09.
  • The P/E Ratio of Biocon Ltd changed from 43.4 on March 2020 to 31 on March 2024 . This represents a CAGR of -6.51% over 5 yearsThe P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 18.4 on March 2024 . This represents a CAGR of -6.39% over 5 years.
  • The Market Cap of Biocon Ltd changed from ₹ 32472 crore on March 2020 to ₹ 31707 crore on March 2024 . This represents a CAGR of -0.48% over 5 yearsThe Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 51797 crore on March 2020 to ₹ 102679 crore on March 2024 . This represents a CAGR of 14.67% over 5 years.
  • The revenue of Biocon Ltd for the Mar '25 is ₹ 4474 crore as compare to the Dec '24 revenue of ₹ 3874 crore. This represent the growth of 15.49% The revenue of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 9056 crore as compare to the Dec '24 revenue of ₹ 8535 crore. This represent the growth of 6.1%.
  • The ebitda of Biocon Ltd for the Mar '25 is ₹ 1135 crore as compare to the Dec '24 ebitda of ₹ 804.7 crore. This represent the growth of 41.11% The ebitda of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 2525 crore as compare to the Dec '24 ebitda of ₹ 2427 crore. This represent the growth of 4.04%.
  • The net profit of Biocon Ltd changed from ₹ 148.9 crore to ₹ 459.4 crore over 8 quarters. This represents a CAGR of 75.65% The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1405 crore to ₹ 1586 crore over 8 quarters. This represents a CAGR of 6.27% .
  • The Dividend Payout of Biocon Ltd changed from 69.72 % on March 2022 to 50.32 % on March 2024 . This represents a CAGR of -10.30% over 3 yearsThe Dividend Payout of Dr Reddys Laboratories Ltd changed from 14.14 % on March 2020 to 15.37 % on March 2024 . This represents a CAGR of 1.68% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Biocon Ltd

  • Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company.
  • Biocon, with its key business verticals of Generics, Biosimilars, Research Services and Novel Biologics, has leveraged its affordable innovation model and scientific capabilities to develop and manufacture both small and large molecules at global scale for the benefit of patients.
  • At present, Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw.
  • Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind.
  • In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International.

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

Biocon Ltd News Hub

News

Biocon Ltd spurts 1.3%, up for five straight sessions

Biocon Ltd rose for a fifth straight session today. The stock is quoting at Rs 343.8, up 1...

Read more

19 May 2025 13:00

News

Biocon's subsidiary get US FDA nod for anticoagulant medication Rivaroxaban

Rivaroxaban is a prescription medication used in the treatment of deep vein thrombosis and...

Read more

16 May 2025 09:38

News

Board of Biocon recommends final dividend

Biocon announced that the Board of Directors of the Company at its meeting held on 8 May 2...

Read more

09 May 2025 09:23

News

Biocon to hold AGM

Biocon announced that the 47th Annual General Meeting(AGM) of the company will be held on ...

Read more

09 May 2025 09:23

News

Biocon edges higher after biologics arm secures multiple market access deals for Yesintek

These agreements include key placements on national and regional formularies. Express Scri...

Read more

05 May 2025 09:31

News

Biocon's board OKs to raise Rs 4,500-cr

'Raising of funds by way of issuance any instrument or security, including equity shares, ...

Read more

24 Apr 2025 08:11

Dr Reddys Laboratories Ltd News Hub

News

DRL's USA facility gets 2 observations from USFDA

The USFDA completed aforementioned inspection and issued form-483 with two observations. H...

Read more

19 May 2025 08:32

News

USFDA completes GMP inspection of Dr Reddy's Middleburgh facility in New York

Dr Reddys Laboratories announced that the United States Food & Drug Administration (USFDA)...

Read more

17 May 2025 11:32

News

Dr Reddys Lab jumps after Q4 PAT rises 22% YoY

Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 cror...

Read more

12 May 2025 14:50

News

Dr Reddys Laboratories AGM scheduled

Dr Reddys Laboratories announced that the 41th Annual General Meeting(AGM) of the company ...

Read more

10 May 2025 10:17

News

Dr Reddys Lab Q4 PAT rises 22% YoY

Revenue from operations rose 20% year-on-year to Rs 8,506 crore, compared to Rs 7,083 cror...

Read more

10 May 2025 10:52

News

Board of Dr Reddys Laboratories recommends Final Dividend

Dr Reddys Laboratories announced that the Board of Directors of the Company at its meeting...

Read more

09 May 2025 17:01

SWOT Analysis Of Biocon Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Biocon Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Biocon Ltd and Dr Reddys Laboratories Ltd

Which company has a larger market capitalization, Biocon Ltd or Dr Reddys Laboratories Ltd?

Market cap of Biocon Ltd is 41,006 Cr while Market cap of Dr Reddys Laboratories Ltd is 101,699 Cr

What are the key factors driving the stock performance of Biocon Ltd and Dr Reddys Laboratories Ltd?

The stock performance of Biocon Ltd and Dr Reddys Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Biocon Ltd and Dr Reddys Laboratories Ltd?

As of May 20, 2025, the Biocon Ltd stock price is INR ₹341.55. On the other hand, Dr Reddys Laboratories Ltd stock price is INR ₹1218.75.

How do dividend payouts of Biocon Ltd and Dr Reddys Laboratories Ltd compare?

To compare the dividend payouts of Biocon Ltd and Dr Reddys Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions